Chembio Diagnostics Inc.

NASDAQ:CEMI   3:59:56 PM EDT
1.01
0.00 (-0.50%)
Products

Chembio Diagnostics - Got Notice On Dec 1, That FDA Requires Additional Data Related To CLIA, Waiver Submission For DPP HIV-Syphilis Test System

Published: 12/08/2021 11:21 GMT
Chembio Diagnostics Inc. (CEMI) - Chembio Diagnostics - on Dec 1, Co Got Notice That FDA Requires Additional Data Related to Clia, Waiver Submission for Dpp Hiv-syphilis Test System.
Chembio Diagnostics Inc - Seeking Additional Data for FDA Request Will Extend Clia Waiver for Dpp Hiv-syphilis Test System for Undeterminable Period.
Further Company Coverage: Cemio ((reuters.
Briefs@thomsonreuters.
Com;;)).